SFDA
沙特食品藥品管理局
Saudi Arabia
Last reviewed 2026-08-05
SFDA根據《醫療器材臨時條例》監管沙特醫療器材。沙特正日益與國際標準（IMDRF）接軌，已引入強制器材備案和不良事件報告。
SFDA MDMA OVERVIEW
The Saudi Food and Drug Authority (SFDA) authorizes medical devices through its Medical Device Market Authorization (MDMA) framework. Manufacturers and authorized representatives submit technical and conformity evidence so devices can be listed for the Kingdom’s market. SFDA is a key reference authority across the GCC and is progressively aligning expectations with IMDRF-style risk classification and quality system evidence.
EVIDENCE AND LOCAL REPRESENTATION
Most pathways rely on recognized conformity assessment packages (for example CE or other reference approvals) plus local establishment registration where required. Labeling, Arabic language requirements, and authorized representative arrangements are common failure points for first-time entrants. Change control after listing must keep SFDA records synchronized with manufacturing and labeling updates.
SURVEILLANCE AND WHY MONITORING MATTERS
Post-market obligations include adverse event reporting and field actions. For multi-market portfolios, SFDA listing status should be watched alongside FDA recalls and EU FSCAs—the same device family may face different timing of safety communications. MedFlux surfaces SFDA-related regulatory signals in the same feed as other authorities so Gulf launches do not run on siloed email alerts.
器材分類
Class A, B, C, D
審批路徑
SFDA device listing / market authorization
核心監管職能
- ▸器材備案（MDMA）
- ▸合格性評估
- ▸不良事件報告
- ▸GCC協調
- ▸進口管控
§ RELATED INTELLIGENCE
§ FAQ
What is SFDA medical device registration in Saudi Arabia?
The SFDA (Saudi Food and Drug Authority) manages medical device registration through its Medical Device Market Authorization (MDMA) system. Devices must be listed in the SFDA database with conformity assessment evidence. Saudi Arabia is aligning with IMDRF standards and serves as a regulatory benchmark for the Gulf Cooperation Council (GCC) region.
Do I need a local representative for SFDA?
Foreign manufacturers typically appoint an authorized establishment in Saudi Arabia to handle MDMA submissions, communications, and post-market duties. Exact requirements depend on the establishment type and device risk class—confirm current SFDA guidance before contracting a representative.
Does SFDA accept FDA or CE evidence?
SFDA commonly relies on recognized international conformity assessment evidence as part of MDMA packages, but acceptance details and document sets can change. Teams should treat FDA clearance or CE certification as supportive—not automatically sufficient—without Saudi-specific labeling and establishment compliance.
MedFlux即時監控SFDA的監管變化、安全警報和市場信號——讓您的團隊不錯過任何關鍵更新。
免費監控{abbr} →